Albuterol Sulfate
Product Images NDC 53002-2584

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 53002-2584). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Albuterol Sulfate Chemical Structure (Albuterolhfa Spl Graphic 01)

Chemical structure diagram of Albuterol Sulfate showing molecular bonds and groups, including the sulfate hydrate component (H2SO4).*

FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Day 1 (Albuterolhfa Spl Graphic 02)

A line graph showing mean percent change from baseline over 6 hours for three treatments: CFC 11/12-propelled albuterol, Albuterol sulfate HFA, and HFA-134a placebo inhaler. The y-axis represents mean % change from baseline (0 to 40%), and the x-axis represents time in hours (0 to 6). Three lines plot their comparative changes through time.*

FDA Label Image

Fev1 As Percent Change From Predose In A Large, 12-week Clinical Trial, Week 12 (Albuterolhfa Spl Graphic 03)

A line chart showing mean percentage change from baseline over 6 hours for three inhalation treatments: CFC 11/12-propelled albuterol, Albuterol sulfate HFA, and HFA-134a placebo inhaler. The chart compares their effects with 2 inhalations taken 4 times daily, illustrating their time-dependent changes in response.*

FDA Label Image

Figure A (Albuterolhfa Spl Graphic 04)

An instructional diagram showing an Albuterol Sulfate HFA inhaler with labeled parts: metal canister, plastic actuator, mouthpiece, counter, and a separate cap. The illustration highlights the components of the inhaler device.*

FDA Label Image

Figure B (Albuterolhfa Spl Graphic 05)

An instructional illustration showing a person using an Albuterol Sulfate HFA inhaler. The hand is pressing down on the inhaler to release a spray, directed toward the mouth, with an arrow indicating the pressing motion. The inhaler includes a dose counter displaying the number 203, and the cap is shown removed and placed below.*

FDA Label Image

Figure C (Albuterolhfa Spl Graphic 06)

An instructional black and white line drawing showing a hand holding an inhaler, which is encased in a protective sleeve. The sleeve has a visible label or marking with the number 200, likely indicating the dose count or capacity of the inhaler device.*

FDA Label Image

Figure D (Albuterolhfa Spl Graphic 07)

An instructional illustration showing the 'Mouthpiece-Down position' for using an inhaler. It depicts a hand holding an inhaler with the mouthpiece pointed downward. The illustration labels the 'Mouthpiece' on the device and separately shows the 'Cap' removed and lying nearby.*

FDA Label Image

Figure E (Albuterolhfa Spl Graphic 08)

An instructional diagram showing a side profile of a person's face exhaling, with text instructing to "Breathe out as much air as you can," emphasizing exhalation through the mouth. A dashed arrow points outward from the mouth, illustrating the direction of breath.*

FDA Label Image

Figure F (Albuterolhfa Spl Graphic 09)

Instructional diagram showing proper use of an inhaler. The image depicts a person holding the inhaler near their mouth with the instruction to push down on the device and breathe in medication.*

FDA Label Image

Figure G (Albuterolhfa Spl Graphic 10)

An instructional illustration demonstrating correct and incorrect use of an inhaler. The top image labeled 'Not blocked' shows the inhaler spray correctly emitting medication. The bottom image labeled 'Blocked' shows the inhaler tip obstructed, preventing proper spray release. The hand grip and inhaler outline are visible in both images.*

FDA Label Image

Figure H (Albuterolhfa Spl Graphic 11)

An instructional diagram showing a hand holding an inhaler over a sink while water is being poured over the inhaler. A detached inhaler cap is shown nearby, indicating it has been removed for cleaning the inhaler device.*

FDA Label Image

Figure I (Albuterolhfa Spl Graphic 12)

An instructional illustration showing a hand holding an oral inhaler device under running water to demonstrate cleaning. A separate inhaler canister is visible to the right, indicating the process involves rinsing the inhaler component with water.*

FDA Label Image

Figure J (Albuterolhfa Spl Graphic 13)

An instructional line drawing showing an inhaler disassembled into three parts: the mouthpiece cover, the canister, and the actuator. Above this, an inset illustrates the correct placement of the inhaler mouthpiece in the mouth, with a crescent moon symbol on the image.*

FDA Label Image

Label Image (Lbl530022584)

Label for Albuterol Sulfate HFA Inhaler by RPK Pharmaceuticals, Inc., containing 200 metered inhalations. The label indicates dosing of two puffs every 4-6 hours as needed. It includes storage instructions, lot number, expiration date, prescribing information, and blank spaces for clinic name and patient details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.